Catalyst Wire Dossier Catalyst Wire Dossier

Lopinavir/ritonavir/ Lamivudine/ Abacavir

· Drugs for Neglected Diseases
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lopinavir/ritonavir/ Lamivudine/ Abacavir, covering 2019-06-07 to 2019-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation [Phase 1, Phase 2]

See pricing